South Korea approves emergency use of Gilead's anti-viral drug to treat COVID-19

South Korea said on Wednesday it has approved the emergency use of Gilead Sciences Inc's remdesivir to treat COVID-19 after a government panel last week cited positive results for the anti-viral drug in other countries.